New Frontiers in Treatment
Why Psychedelic-Assisted Therapy?
BECAUSE it works, psychedelics help people get to the root of their problem in a therapeutic setting:
- MDMA helps individuals with trauma open up and process difficult memories with their therapist’s support. Very effective for PTSD.
- Psilocybin in therapeutic settings helps to facilitate experiences that promote self-reflection, emotional exploration, and personal growth.
- Ketamine allows individuals to explore and process difficult emotions and memories in a supportive clinical environment.
PTSD is Too Common
PTSD is a debilitating and often life-threatening affliction for many Canadian veterans. 10 to 15% of Canadian Veterans (46,000 to 70,000 members) have been diagnosed with PTSD.
Current Supports Limited
Current supports from Veterans Affairs Canada have limited impact on PTSD symptoms. When those diagnosed with military-related PTSD are treated with conventional therapies and medications, most retain their PTSD diagnosis
Effective Treatment
Psychedelic-assisted therapy is more cost-effective. Months and years of talking therapies and long-term prescription medication are more costly than what can be gained in psychedelic-assisted therapy sessions.
Legally Available
Ketamine is legal. Both MDMA and Psilocybin is legally available through Health Canada’s Special Access Program. Cost is a barrier as Veterans Affairs Canada (VAC) does not fund these therapies today.
It Transforms Lives
In a recent trial of MDMA-assisted therapy for PTSD, 88% of participants reported a significant reduction in symptoms, and 67% no longer met the diagnostic criteria for PTSD two months after treatment.
Not Supported
Veteran’s Affairs Canada wants to see more research before they fund this, but it’s been proven and the need is urgent. Help us help the government change this and help veterans.
